BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10414894)

  • 1. Persistent opacification of the left ventricle and myocardium with a new echo contrast agent.
    Strauss AL; Beller KD
    Ultrasound Med Biol; 1999 Jun; 25(5):763-9. PubMed ID: 10414894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast ultrasonography for 2-D opacification of heart cavities, peripheral vessels, kidney and muscle.
    Strauss AL; Beller KD
    Ultrasound Med Biol; 1997; 23(7):975-82. PubMed ID: 9330441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
    Leischik R; Beller KD; Erbel R
    Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent harmonic imaging and videodensitometry significantly enhance ability of intravenous air-filled ultrasonographic contrast agent to produce ventricular and myocardial opacification.
    Sieswerda GT; Kamp O; van den Ende R; Visser CA
    J Am Soc Echocardiogr; 2001 Jan; 14(1):20-8. PubMed ID: 11174430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacification.
    Hausnerova E; Gottdiener JS; Gould JJ; Pezzullo JC; Callahan JD; Cohen JL; Bruns DE; Kuvelas MT; West HE; Dittrich HC
    J Am Soc Echocardiogr; 1999 Nov; 12(11):957-66. PubMed ID: 10552357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects.
    Beppu S; Matsuda H; Shishido T; Matsumura M; Miyatake K
    J Am Soc Echocardiogr; 1997; 10(1):11-24. PubMed ID: 9046489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of modified spherosome suspension (BY963) leads to an increase of acoustic impedance in dog brain tissue.
    Seidel G; Beller KD; Kaps M
    J Neuroimaging; 1998 Jul; 8(3):164-8. PubMed ID: 9664853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimal setting of focus points for myocardial contrast echocardiography with intravenous Optison (FS-69): an experimental study].
    Daimon M; Beppu S; Ishikura F; Ueda H; Kobayashi H; Kashiwagi Y; Yagura S; Yoshikawa J
    J Cardiol; 2001 Apr; 37(4):201-7. PubMed ID: 11337929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of different gases on acoustic properties of a spherosome-based ultrasound contrast agent (BY963). A transcranial Dopplersonography study.
    Seidel G; Beller KD; Aaslid R; Hummel RP; Thibaut U; Vidal-Langwasser M; Kukat B; Kaps M
    J Neuroimaging; 1998 Apr; 8(2):83-7. PubMed ID: 9557145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.
    Porter TR; Xie F; Kilzer K
    J Am Soc Echocardiogr; 1995; 8(5 Pt 1):710-8. PubMed ID: 9417215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular opacification after peripheral venous injection of a modified albumin solution.
    Lin SL; Lo JH; Mou CY; Ho SJ; Liu RH; Chan JY; Chang MS; Chiang HT; Chen CY
    Int J Card Imaging; 1992; 8(1):53-61. PubMed ID: 1619305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial contrast echocardiography from peripheral venous injection: the potential for detection of myocardial perfusion abnormality].
    Matsumura M
    Nihon Rinsho; 1998 Apr; 56(4):914-20. PubMed ID: 9577608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
    Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P
    J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular opacification by intravenous contrast echocardiography.
    Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
    G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
    Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
    J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymer microparticles for right and left heart echocardiography and imaging myocardial perfusion after peripheral vein injection].
    Zotz R; Genth S; Grande J; Walch A; Ziehn P; Krone V; Schuler G
    Z Kardiol; 1996 Dec; 85(12):924-31. PubMed ID: 9082670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in left ventricular cavitary attenuation and improvement in posterior myocardial contrast with higher molecular weight intravenous perfluorocarbon-exposed sonicated dextrose albumin microbubbles.
    Porter TR; Xie F; Kricsfeld A; Deligonul U; Kilzer K
    J Am Soc Echocardiogr; 1996; 9(4):437-41. PubMed ID: 8827626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.